NovAccess Global Inc

PINK:XSNX USA Biotechnology
Market Cap
$2.72
Market Cap Rank
#44633 Global
#14121 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$1.00
About

NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.

NovAccess Global Inc (XSNX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2024: 0.008x

Based on the latest financial reports, NovAccess Global Inc (XSNX) has a cash flow conversion efficiency ratio of 0.008x as of September 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-58.87K) by net assets ($-7.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NovAccess Global Inc - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how NovAccess Global Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

NovAccess Global Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NovAccess Global Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for NovAccess Global Inc (2004–2024)

The table below shows the annual cash flow conversion efficiency of NovAccess Global Inc from 2004 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-09-30 $-7.80 Million $-624.64K 0.080x 0.00%
2023-09-30 $-7.80 Million $-624.64K 0.080x -58.75%
2022-09-30 $-4.65 Million $-903.49K 0.194x +11.78%
2021-09-30 $-3.93 Million $-682.33K 0.174x +565.40%
2020-09-30 $-3.57 Million $-93.19K 0.026x +792.25%
2019-09-30 $-2.24 Million $-6.54K 0.003x -89.05%
2018-09-30 $-4.64 Million $-123.97K 0.027x -37.76%
2017-09-30 $-1.04 Million $-44.84K 0.043x -79.01%
2016-09-30 $-840.45K $-171.97K 0.205x -13.11%
2015-09-30 $-879.25K $-207.07K 0.236x -42.28%
2014-09-30 $-902.78K $-368.37K 0.408x -26.78%
2013-09-30 $-792.63K $-441.72K 0.557x -77.83%
2012-09-30 $-150.90K $-379.24K 2.513x +18.22%
2011-09-30 $-525.80K $-1.12 Million 2.126x -33.86%
2010-09-30 $-419.16K $-1.35 Million 3.215x +154.22%
2009-09-30 $482.81K $-2.86 Million -5.928x -3716.51%
2008-09-30 $5.43 Million $-843.42K -0.155x 0.00%
2007-09-30 $5.43 Million $-843.42K -0.155x +49.65%
2006-09-30 $6.30 Million $-1.94 Million -0.309x -115.65%
2005-09-30 $-532.55K $-1.05 Million 1.971x -96.70%
2004-09-30 $-24.05K $-1.44 Million 59.738x --